August 4, 2012

Honored to be a 2012 Frost & Sullivan Award Recipient

It is an honor to be recognized by Frost & Sullivan for our cost-effective protein production methodology, along with highest specific yields (mg/per DW) of biologics in the industry. The 2012 Frost & Sullivan Award for Technology Innovation has proven that our recombinant protein technology is promising for the future of the industry. Not only have we succeeded by drastically reducing the procedural steps involved in expression and purification of biologics, but we have also been able to create an environmentally friendly process via a biodegradable media platform. We seek to be the future leader of bio-manufacturing for both CRO and CMO services.